ArticleBiochemistry and biophysics reports2026
Evaluation of the antioxidant and anti-inflammatory efficacy of fermented
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fermentation may enhance the skincare potential of the traditional Chinese medicine Methods: A UV-induced zebrafish skin oxidative stress model was established. Embryos were treated with FPS at concentrations of 0.05, 0.10, or 0.20 mg/mL. Evaluations included fin morphology, reactive oxygen species (ROS) levels, activities of antioxidant enzymes (SOD, CAT), malondialdehyde (MDA) content, skin cell apoptosis, and expression of inflammatory genes (PPAR-γ, NF-κB, iκbαa, AP-1). Additionally, a sodium lauryl sulfate (SLS)-induced inflammation model was used to assess neutrophil recruitment. Results: FPS treatment dose-dependently ameliorated UV-induced fin shrinkage and significantly reduced ROS accumulation. At 0.20 mg/mL, FPS markedly elevated SOD and CAT activities while decreasing MDA levels (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.